dc.creatorThiermann, E.
dc.creatorApt Baruch, Werner
dc.creatorAtías, Antonio
dc.creatorLorca, M.
dc.creatorOlguín, J.
dc.date.accessioned2019-01-29T15:46:06Z
dc.date.available2019-01-29T15:46:06Z
dc.date.created2019-01-29T15:46:06Z
dc.date.issued1978
dc.identifierAmerican Journal of Tropical Medicine and Hygiene, Volumen 27, Issue 4, 2018, Pages 747-750
dc.identifier00029637
dc.identifier10.4269/ajtmh.1978.27.747
dc.identifierhttp://repositorio.uchile.cl/handle/2250/162329
dc.description.abstractThe effectiveness of five treatment regimens was compared in mice during acute and late infection with Toxoplasma gondii. Parasitic cure rates, as judged by failure of brain tissue from surviving mice to produce infection when inoculated into clean mice, were as follows: pyrimethamine + sulfamethoxypyridazine, 92%; clindamycin + sulfamethoxypyridazine, 75%; spiramycin + sulfamethoxypyridazine, 16.7%; trimethoprim + sulfamethoxazole, 16.7%; sulfamethoxypyridazine alone, 0%. Pyrimethamine + sulfamethoxypyridazine was the most effective combination against acute toxoplasmosis in mice.
dc.languageen
dc.rightshttp://creativecommons.org/licenses/by-nc-nd/3.0/cl/
dc.rightsAttribution-NonCommercial-NoDerivs 3.0 Chile
dc.sourceAmerican Journal of Tropical Medicine and Hygiene
dc.subjectParasitology
dc.subjectInfectious Diseases
dc.subjectVirology
dc.titleA comparative study of some combined treatment regimens in acute toxoplasmosis in mice
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución